Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Article One Partners (AOP) is a leading intellectual property research firm that utilizes a global crowdsourcing platform to provide patent validation and landscape analysis. Founded in 2008, the company maintains a community of over 40,000 researchers, including scientists and technologists, who uncover prior art to assist clients in patent litigation and strategic IP management. AOP serves a significant portion of the Fortune 100, particularly within the pharmaceutical, biotechnology, and medical device sectors, where intellectual property quality is critical. The company was acquired by RWS Group in 2017, integrating its crowdsourced research capabilities into a broader suite of language and IP support services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Article One.